Press Room

News / Aug 09, 2021

Our knowledge is available 365 days for you

Summer series

Knowledge 365 our experts content always available | Hovione

Our knowledge is available 365 days for you.
Count on our multidisciplinary teams to exchange knowledge, ideas, and experience to develop and improve your project. As a specialist integrated CDMO we are dedicated to helping you bring new and off-patent drugs to market faster.

Challenge us

 

Our scientists attend the leading events of the pharma industry throughout the year where they share their knowledge and present their innovative work.
 

Did you miss the articles on Pharmaceutical Technology, Drug Development & Delivery, On-Drug Delivery or Chemistry Today? You are still in time to read them. Access them here: 
 

pharmatech logo | Hovione

 

Drug Development and Delivery Logo | Hovione

 

Moving Beyond
Particle Size Control

Contributors:
João Henriques (Group Leader,
R&D Drug Product Development)
Mafalda Paiva (Group Leader, Analytical Development)


 
Improving Bioavailability
& Solubility: Each Molecule
Is Unique - Emerging Platforms
Address Extreme Compounds

Contributor: João Henriques
(Group Leader, R&D
Drug Product Development)


 
ondrugdelivery logo | Hovione

 

chemistry today chimica oggi logo | Hovione

 

Semi-Automation in
Inhaler Testing - Exploring
the Potential & Practicalities

Discussion with João Pereira
(Team Leader, R&D Analytical Development)
Raquel Borda d' Água
(Associate Analytical Chemist, R&D Analytical Development; Copley) 


 
Where Continuous Flow
can help in today’s
Pharmaceutical Industry

Panel Discussion with
Rudi Oliveira
(Scientist, R&D Process
Engineering and Scale-up)

 

 

 

 

 

 

 

Did you miss our presentations at DDF, RDD, DDL or AIChE?
You are still in time to join. Access them here:

 

 

ddf summit 2021 logo | Hovione

 

rdd 2021 logo | Hovione

 

Technology & Innovation

Performance Enhancement Strategies for
Low Solubility APIs – do more with less

Authors: Mafalda Paiva &
João Henriques
 

Workshop Presentation

Fully Integrated
DPI Development
From API To Device

Authors: João Pereira,
Beatriz Noriega Fernandes

aiche 2020 logo | Hovione

 

ddl 2020 logo | Hovione

 

Predictive Scale-Up/Scale-Down for Production of Pharmaceuticals

Reaction Kinetic Model
Application to Speed up Development

Author: Filipe Ataíde
 

Presentation
and Paper

Spray-dried composite
formulation for lung
sustained release

Author: Beatriz Noriega Fernandes

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025